Literature DB >> 1769732

Acid-stable protease inhibitor in chronic phase of carrageenin-induced inflammation in rats.

M Sugiki1, M Maruyama, E Yoshida, H Sumi, H Mihara.   

Abstract

The activity and kinetics of acid-stable protease inhibitor (ASPI) were investigated in the chronic phase of carrageenin-induced inflammation in rats. The ASPI activity was 19.6 +/- 3.1 units/ml in the plasma and 15.4 +/- 2.1 units/ml in the inflammatory exudate. The plasma value was significantly higher than that of the control (11.6 +/- 1.3 units/ml). A kinetics study was performed using purified and radiolabeled rat plasma ASPI, whose NH2-terminal amino acid sequence was Ala-Val-Leu-Pro-Gln-Glu-Asn-Glu-Gly-X-Gly-Ser-Glu-Pro-Leu-Ile-Thr-Gly-Th r-Leu- Lys-Lys-Glu-Asp-Ser-Asn-Gln-Leu-Lys-Tyr-Ser-Glu-Gly-Pro. The half-life of the distributive phase was 4.3 +/- 0.4 min and that of the postdistributive phase (biological half-life) was 42.2 +/- 9.2 min in inflammation. There was no significant difference compared with the values in the control (3.9 +/- 0.4 min and 40.7 +/- 6.5 min, respectively). It appeared that the increase in ASPI in inflammation was not due to prolonged excretion of the inhibitor but to an increased production of it, and ASPI was rapidly distributed to the fluids and tissues.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1769732     DOI: 10.1007/bf00917313

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  26 in total

1.  [About degradation products of the inter-alpha-trypsin inhibitor in serum. I. The inter-alpha-trypsin inhibitor as precursor of the acid stable trypsin-plasmin-inhibitor of the serum (author's transl)].

Authors:  K Hochstrasser; J Niebel; H Feuth; K Lempart
Journal:  Klin Wochenschr       Date:  1977-04-01

2.  [The inter-alpha-trypsin inhibitor as precursor of the acid-stable proteinase inhibitors in human serum and urine].

Authors:  K Hochstrasser; G Bretzel; H Feuth; W Hilla; K Lempart
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1976-02

3.  [Clinical value of the determination of urinary antitrypsin activity].

Authors:  D Gosset; C Mizon; P Savinel; M Balduyck; B Boniface; P Y Hatron; J Mizon; B Devulder
Journal:  Presse Med       Date:  1988-02-27       Impact factor: 1.228

4.  Purification and amino acid analysis of plasma acid stable trypsin inhibitor.

Authors:  M Maruyama; T Yamamoto; H Sumi; H Tsushima; H Mihara; N Minamino
Journal:  Enzyme       Date:  1986

5.  Acid-stable trypsin-plasmin inhibitors formed enzymatically from plasma precursor protein.

Authors:  H Sumi; E Yoshida; H Hamada; H Mihara
Journal:  Biochim Biophys Acta       Date:  1988-07-14

6.  Isolation of urinary trypsin inhibitor-like inhibitor from human lung cancer tissue.

Authors:  T Okumichi; M Nishiki; S Takasugi; N Toki; H Ezaki
Journal:  Cancer Res       Date:  1984-05       Impact factor: 12.701

7.  Plasminogen activator in synovial fluid from patients with rheumatoid arthritis.

Authors:  H Kikuchi; S Tanaka; O Matsuo
Journal:  J Rheumatol       Date:  1987-06       Impact factor: 4.666

8.  Acid stable protease inhibitor in ascites of ovarian carcinoma.

Authors:  K Akazawa; H Sumi; M Maruyama; H Mihara
Journal:  Clin Chim Acta       Date:  1983-06-30       Impact factor: 3.786

9.  Acid stable trypsin inhibitor in bile.

Authors:  T Yamamoto; H Sumi; M Maruyama; H Mizumoto; R Ikeda; H Yoshihara; H Mihara
Journal:  Clin Chim Acta       Date:  1986-07-15       Impact factor: 3.786

10.  Isolation and characterization of an inter-alpha-trypsin inhibitor-IgG complex from human serum.

Authors:  J P Salier; R Sesboüé; K Hochstrasser; O Schönberger; J P Martin
Journal:  Biochim Biophys Acta       Date:  1983-01-12
View more
  3 in total

1.  Plasma bikunin: half-life and tissue uptake.

Authors:  Aneta Kaczmarczyk; Anna M Blom; James Alston-Smith; Mats Sjöquist; Erik Fries
Journal:  Mol Cell Biochem       Date:  2005-03       Impact factor: 3.396

2.  Plasma clearance of rat bikunin: evidence for receptor-mediated uptake.

Authors:  E M Sjöberg; A Blom; B S Larsson; J Alston-Smith; M Sjöquist; E Fries
Journal:  Biochem J       Date:  1995-06-15       Impact factor: 3.857

3.  Effect of ulinastatin on the rocuronium-induced neuromuscular blockade.

Authors:  Min Soo Kim; Jung Woo Park; Yun Hee Lim; Byung Hoon Yoo; Jun Heum Yon; Dong Won Kim
Journal:  Korean J Anesthesiol       Date:  2012-03-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.